BioPharma Dive 28. Jan. 2026 Lilly bets on Seamless, delving further into genetic medicine for hearing loss
BioPharma Dive 14. Jan. 2026 Lilly, chasing Novo, expects second-quarter FDA decision on obesity pill
BioPharma Dive 18. Dez. 2025 Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial